Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Joshua L. Fenderson"'
Autor:
Joshua L. Fenderson, Amy N. Stratton, Jennifer S. Domingo, Gerald O. Matthews, Christopher D. Tan
Publikováno v:
Case Reports in Psychiatry, Vol 2013 (2013)
The aim of this paper is to report the first case of atomoxetine leading to false-positive urine drug screen. An otherwise healthy 27-year-old female with a history of attention deficit hyperactivity disorder (ADHD) treated with atomoxetine had an ac
Externí odkaz:
https://doaj.org/article/a2b03442ca344527943daca7cba958af
Autor:
Matthew J. Rendo, Guy T. Clifton, Anne E O'Shea, Alexandra M Adams, Timothy J. Vreeland, Joshua L. Fenderson, Patrick M. McCarthy, Daniel W. Nelson, Katherine M Cebe, Robert W Krell, George E. Peoples, Matthew D Uy
Publikováno v:
OncoTargets and therapy
Pancreatic ductal adenocarcinoma (PDAC) remains deadly despite advances in systemic therapies and surgical techniques. While there is increasing utilization of immune therapies across diverse cancer types, PDAC remains generally resistant to these tr
Autor:
Paul Gonzales, Daniel V. Foster, Joshua L. Fenderson, Misty Thompson, Cesar Rosa, Michael B. Adams
Publikováno v:
GastroHep. 2:257-259
Autor:
Joshua L Fenderson, Jeremy A Smith
Publikováno v:
JCO Oncology Practice. 16:519-521
Autor:
Kenneth W. Davis, Joshua L. Fenderson, Matthew J. Rendo, Colby S. McIntosh, Jason B. Corley, M. Adam Meledeo, Andrew P. Cap, Grantham C. Peltier
Publikováno v:
Transfusion. 59:1560-1567
Background Cryoprecipitate's shelf life is limited due to concerns over decreased clotting factor activity and contamination with extended storage. Hemostatic characteristics of thawed cryoprecipitate stored up to 35 days at refrigerated and room tem
Publikováno v:
Cureus
Hemophagocytic lymphohistiocytosis (HLH) is a severe systemic inflammatory syndrome that is often fatal. In the adult population, it is believed to develop secondary to immune dysregulation due to rheumatologic, infectious, malignant, and recently, i
Publikováno v:
Journal of Oncology Practice. 15:55-57
Publikováno v:
Hawai'i journal of medicinepublic health : a journal of Asia Pacific MedicinePublic Health. 76(11 Suppl 2)
Hypoplastic Myelodysplastic Syndrome (h-MDS) comprises 15% of all MDS and has traditionally been difficult to distinguish from aplastic anemia (AA) by current testing. Accurate differentiation is important because treatment and prognosis differ. Sinc
Autor:
Stephen W. Olson, Dustin J. Little, John S. Thurlow, Joshua L. Fenderson, Alison A. Linberg, Kevin C. Abbott
Publikováno v:
American Journal of Kidney Diseases. 63:167-170